Presentations 2026
Conference on Retrovirus and Opportunistic Infections (CROI 2026), Denver, Colorado, USA, 22-25 February 2026
Poster presentation:
Evaluating the impact of integrase inhibitors (INSTIs) on cardiovascular disease (CVD) presented by Bastian Neesgaard on behalf of the RESPOND study group. Poster
Evaluating the impact of integrase inhibitors (INSTIs) on cardiovascular disease (CVD) presented by Bastian Neesgaard on behalf of the RESPOND study group. Poster
International Workshop on HIV and Hepatitis Observational Databases, Thessaloniki, Greece, 26-29 March 2026
Poster presentation:
Risk of fracture with contemporary antiretrovirals within the RESPOND Consortium presented by Bastian Neesgaard on behalf of the RESPOND study group.
AIDS 2026, the 26th International AIDS Conference, Rio de Janeiro, Brazil, 26-31 July 2026.
Accepted as Poster presentations:
Risk of fracture with contemporary antiretrovirals within the RESPOND Consortium will be presented by Bastian Neesgaard on behalf of the RESPOND study group.
Association between integrase inhibitors (INSTIs) and tenofovir alafenamide (TAF) and moderate chronic kidney disease (CKD) in the RESPOND HIV cohort collaboration will be presented by Lauren Greenberg on behalf of the RESPOND study group.